4//SEC Filing
Requadt Scott 4
Accession 0000899243-22-026986
CIK 0001827506other
Filed
Jul 27, 8:00 PM ET
Accepted
Jul 28, 7:52 PM ET
Size
7.5 KB
Accession
0000899243-22-026986
Insider Transaction Report
Form 4
Requadt Scott
DirectorSee Remarks
Transactions
- Purchase
Common Stock
2022-07-28$4.25/sh+3,090$13,133→ 469,298 total - Purchase
Common Stock
2022-07-26$4.24/sh+5,528$23,439→ 466,208 total
Holdings
- 449,766(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.18 to $4.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- [F2]These shares are held by Requadt Family Limited Partnership. The Reporting Person has voting and dispositive power over the shares beneficially owned by Requadt Family Limited Partnership.
Documents
Issuer
Talaris Therapeutics, Inc.
CIK 0001827506
Entity typeother
Related Parties
1- filerCIK 0001664852
Filing Metadata
- Form type
- 4
- Filed
- Jul 27, 8:00 PM ET
- Accepted
- Jul 28, 7:52 PM ET
- Size
- 7.5 KB